X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4171) 4171
Publication (465) 465
Newsletter (214) 214
Book Review (60) 60
Book Chapter (51) 51
Government Document (49) 49
Conference Proceeding (13) 13
Newspaper Article (13) 13
Book / eBook (9) 9
Dissertation (4) 4
Magazine Article (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3271) 3271
neurofibromatosis (1940) 1940
index medicus (1775) 1775
female (1646) 1646
male (1598) 1598
adult (1042) 1042
child (994) 994
neurofibromatosis 1 - complications (885) 885
adolescent (826) 826
clinical neurology (757) 757
tumors (751) 751
oncology (715) 715
middle aged (687) 687
surgery (653) 653
child, preschool (622) 622
children (568) 568
neurofibromatosis type 1 (536) 536
magnetic resonance imaging (523) 523
neurofibromatosis 1 - pathology (513) 513
cancer (508) 508
pediatrics (507) 507
animals (484) 484
neurofibromatosis type-1 (483) 483
research (478) 478
neurofibromatosis 1 - genetics (474) 474
neurofibromatosis 1 - diagnosis (445) 445
mutation (401) 401
nf1 (396) 396
treatment outcome (393) 393
care and treatment (386) 386
infant (382) 382
aged (372) 372
diagnosis (350) 350
mice (345) 345
medicine & public health (331) 331
neurosciences (321) 321
retrospective studies (306) 306
genetics & heredity (301) 301
article (287) 287
neurofibromatosis 1 - therapy (283) 283
genetic aspects (279) 279
management (277) 277
young adult (275) 275
follow-up studies (268) 268
prognosis (268) 268
analysis (254) 254
health aspects (232) 232
diagnosis, differential (229) 229
tomography, x-ray computed (220) 220
risk factors (218) 218
gliomas (217) 217
pathology (217) 217
chemotherapy (209) 209
neoplasms (207) 207
gene (202) 202
neurology (202) 202
expression (199) 199
neurofibromatosis 1 (195) 195
growth (191) 191
patients (186) 186
nerve sheath tumors (185) 185
type-1 (184) 184
disease (181) 181
recklinghausen's disease (177) 177
neurofibromatosis type 2 (176) 176
neurofibromatosis 1 - drug therapy (171) 171
mutations (170) 170
cell biology (169) 169
neurofibromin 1 - genetics (169) 169
neurofibroma (163) 163
congenital, hereditary, and neonatal diseases and abnormalities (161) 161
malignant peripheral nerve sheath tumor (161) 161
radiotherapy (161) 161
vestibular schwannoma (161) 161
medicine (156) 156
signal transduction (154) 154
childhood (153) 153
schwannoma (151) 151
neurosurgery (150) 150
immunohistochemistry (148) 148
neurofibromatosis 1 - surgery (148) 148
nervous system diseases (147) 147
nerve sheath neoplasms - pathology (146) 146
combined modality therapy (144) 144
otorhinolaryngology (144) 144
medical research (143) 143
disease models, animal (141) 141
development and progression (140) 140
genes, neurofibromatosis 1 (140) 140
case report (136) 136
neurofibromatosis type-2 (136) 136
radiology, nuclear medicine & medical imaging (136) 136
vonrecklinghausen neurofibromatosis (136) 136
neurilemmoma - pathology (134) 134
phenotype (134) 134
proteins (134) 134
therapy (134) 134
genetics (130) 130
neurofibromatosis 1 - metabolism (130) 130
nf2 (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4209) 4209
German (82) 82
French (64) 64
Japanese (36) 36
Spanish (24) 24
Polish (15) 15
Italian (10) 10
Russian (9) 9
Dutch (6) 6
Hungarian (6) 6
Portuguese (5) 5
Chinese (4) 4
Czech (4) 4
Croatian (3) 3
Hebrew (3) 3
Korean (3) 3
Danish (2) 2
Bosnian (1) 1
Finnish (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 10/2008, Volume 113, Issue S7, pp. 1807 - 1843
Pancreatic endocrine tumors (PETs) can occur as part of 4 inherited disorders, including Multiple Endocrine Neoplasia type 1 (MEN1), von Hippel‐Lindau disease... 
pancreatic endocrine tumors | Multiple Endocrine Neoplasia type 1 | von Hippel‐Lindau disease | insulinomas | Zollinger‐Ellison syndrome | tuberous sclerosis | neurofibromatosis 1 | neuroendocrine tumors | gastrinomas | Pancreatic endocrine tumors | Gastrinomas | Insulinomas | Zollinger-Ellison syndrome | Tuberous sclerosis | Multiple endocrine neoplasia type 1 | Neurofibromatosis 1 | Neuroendocrine tumors | Von Hippel-Lindau disease | SOMATOSTATIN-RECEPTOR SCINTIGRAPHY | NEOPLASIA-TYPE-I | von Hippel-Lindau disease | HIPPEL-LINDAU-DISEASE | GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | ZOLLINGER-ELLISON-SYNDROME | GASTRIC-ACID HYPERSECRETION | POSITRON-EMISSION-TOMOGRAPHY | TUBEROUS SCLEROSIS COMPLEX | ONCOLOGY | ISLET-CELL TUMORS | VON-RECKLINGHAUSENS-DISEASE | von Hippel-Lindau Disease - therapy | Prognosis | Pancreatic Neoplasms - diagnosis | Humans | Multiple Endocrine Neoplasia Type 1 - diagnosis | Neurofibromatosis 1 - diagnosis | Pancreatic Neoplasms - genetics | von Hippel-Lindau Disease - genetics | Multiple Endocrine Neoplasia Type 1 - genetics | Neurofibromatosis 1 - therapy | Tuberous Sclerosis - genetics | Tuberous Sclerosis - therapy | von Hippel-Lindau Disease - diagnosis | Multiple Endocrine Neoplasia Type 1 - therapy | Tuberous Sclerosis - diagnosis | Neurofibromatosis 1 - genetics | Pancreatic Neoplasms - therapy | Development and progression | Pancreatic tumors | Genetic aspects | multiple endocrine neoplasia type 1
Journal Article
Neuro-Oncology, ISSN 1522-8517, 10/2012, Volume 14, Issue 10, pp. 1265 - 1284
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. e46 - e53
Although the neurofibromatoses consist of at least three autosomal dominantly inherited disorders, neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and... 
GENOTYPE-PHENOTYPE CORRELATION | WHOLE-BODY MRI | FAMILIAL SCHWANNOMATOSIS | POSITRON-EMISSION-TOMOGRAPHY | VONRECKLINGHAUSEN NEUROFIBROMATOSIS | GENETIC-LINKAGE | PLEXIFORM NEUROFIBROMAS | ONCOLOGY | SHEATH TUMORS | TYPE-1 NF1 | MISMATCH REPAIR DEFICIENCY | Skin Neoplasms - diagnostic imaging | Skin Neoplasms - therapy | Central Nervous System Neoplasms - genetics | Humans | Neurilemmoma - diagnostic imaging | Neurofibromatosis 1 - diagnostic imaging | Optic Nerve Glioma - genetics | Central Nervous System Neoplasms - therapy | Infant | Optic Nerve Glioma - diagnostic imaging | Neurofibromatoses - genetics | Neurofibromatosis 1 - therapy | Optic Nerve Glioma - therapy | Magnetic Resonance Imaging | Neurilemmoma - therapy | Neurilemmoma - genetics | Central Nervous System Neoplasms - diagnostic imaging | Skin Neoplasms - genetics | Adolescent | Neurofibromatosis 1 - genetics | Child | Neurofibromatoses - diagnostic imaging | Neurofibromatoses - therapy | Pediatrics | Leukemia | Brain tumors | Central nervous system | Parents | Rhabdomyosarcoma | Neurofibromin 2 | Neurofibromatosis 2 | Cognition | Malignancy | Genetic screening | Risk factors | Osteoprotegerin | Children | Astrocytoma | Myelomonocytic leukemia | Organs | Health risks | Recklinghausen's disease | Morbidity | Hereditary diseases | Magnetic resonance imaging | Surveillance | Glioma | Neurofibromatosis | Diagnostic systems | Cancer | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 56, pp. 77 - 84
Journal Article